Bladder Tumor Diagnosis, Treatment and Follow-up Results in Our Hospital

Hayriye Canik Yaşar; Fatma Zeynep Özen; Adem Yaşar

Makale detayları

Bladder Tumor Diagnosis, Treatment and Follow-up Results in Our Hospital

Yazarlar:

Hayriye Canik Yaşar | Fatma Zeynep Özen | Adem Yaşar

Yayıncı:

Tokat Gaziosmanpasa University

Ana Başlıklar:

Klinik Tıp Bilimleri

Dergi:

Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi Vol.16 Issue 1, pp.1-6

Belge Tipi:

Makale

Yayın Tarihi:

2/2024

Belge Dili:

Türkçe

Document ID (Org No.):

2001320449

pISSN:

1309-3320

Anahtar kelimeler:

Özet:

 Objectives: In this study, we aimed to present the demographic characteristics, pathological evaluation results, prognosis and progression of patients who underwent transurethral resection TUR with the diagnosis of bladder cancer in the urology clinic of Amasya Sabuncuoğlu Şerefettin Training and Research Hospital in the last 5 years. Materials and Methods: In our hospital, between January 2016 and January 2022, TUR was performed with a preliminary diagnosis of bladder cancer and bladder carcinoma was found as a result of pathology; 252 patients whose data were obtained by scanning the hospital system were evaluated retrospectively. Results: While the mean age was 584.3 years in males, it was 652.4 years in females. The mean follow-up period was 315.2 months. Looking at the tumor type, 78 were papillary, 15 were solid and 7 were mixed. According to pathological data, 92 of the patients had urethelial carcinoma, 4 had squamous carcinoma, 3 had adenocarcinoma, and 1 had neuroendocrine tumor. Intracavitary treatment was applied in 162 of 252 patients, 145 of them were using BCG and 17 of them were using Epirubicin. It was observed that 80 of non-relapsed patients received intracavitary treatment, and 40 of those with relapses received intracavitary treatment. Conclusion: In our hospital, TUR is used as the gold standard in the diagnosis and treatment of bladder tumor, and intracavitary treatment and control cystoscopies are performed in accordance with the guidelines after pathological evaluation.

 Objectives: In this study, we aimed to present the demographic characteristics, pathological evaluation results, prognosis and progression of patients who underwent transurethral resection TUR with the diagnosis of bladder cancer in the urology clinic of Amasya Sabuncuoğlu Şerefettin Training and Research Hospital in the last 5 years. Materials and Methods: In our hospital, between January 2016 and January 2022, TUR was performed with a preliminary diagnosis of bladder cancer and bladder carcinoma was found as a result of pathology; 252 patients whose data were obtained by scanning the hospital system were evaluated retrospectively. Results: While the mean age was 584.3 years in males, it was 652.4 years in females. The mean follow-up period was 315.2 months. Looking at the tumor type, 78 were papillary, 15 were solid and 7 were mixed. According to pathological data, 92 of the patients had urethelial carcinoma, 4 had squamous carcinoma, 3 had adenocarcinoma, and 1 had neuroendocrine tumor. Intracavitary treatment was applied in 162 of 252 patients, 145 of them were using BCG and 17 of them were using Epirubicin. It was observed that 80 of non-relapsed patients received intracavitary treatment, and 40 of those with relapses received intracavitary treatment. Conclusion: In our hospital, TUR is used as the gold standard in the diagnosis and treatment of bladder tumor, and intracavitary treatment and control cystoscopies are performed in accordance with the guidelines after pathological evaluation.

 Objectives: In this study, we aimed to present the demographic characteristics, pathological evaluation results, prognosis and progression of patients who underwent transurethral resection TUR with the diagnosis of bladder cancer in the urology clinic of Amasya Sabuncuoğlu Şerefettin Training and Research Hospital in the last 5 years. Materials and Methods: In our hospital, between January 2016 and January 2022, TUR was performed with a preliminary diagnosis of bladder cancer and bladder carcinoma was found as a result of pathology; 252 patients whose data were obtained by scanning the hospital system were evaluated retrospectively. Results: While the mean age was 584.3 years in males, it was 652.4 years in females. The mean follow-up period was 315.2 months. Looking at the tumor type, 78 were papillary, 15 were solid and 7 were mixed. According to pathological data, 92 of the patients had urethelial carcinoma, 4 had squamous carcinoma, 3 had adenocarcinoma, and 1 had neuroendocrine tumor. Intracavitary treatment was applied in 162 of 252 patients, 145 of them were using BCG and 17 of them were using Epirubicin. It was observed that 80 of non-relapsed patients received intracavitary treatment, and 40 of those with relapses received intracavitary treatment. Conclusion: In our hospital, TUR is used as the gold standard in the diagnosis and treatment of bladder tumor, and intracavitary treatment and control cystoscopies are performed in accordance with the guidelines after pathological evaluation.

 Amaç: Biz bu çalışmamızda Amasya Sabuncuoğlu Şerefettin Eğitim Araştırma Hastanesi üroloji kliniğinde son 5 yıl içerisinde mesane kanseri tanısı ile transüretral rezeksiyon TUR yapılan hastaların demografik özellikleri, patolojik değerlendirme sonuçları, prognoz ve progresyonlarını irdeleyerek sunmayı amaçladık Gereç ve yöntem: Hastanemizde Ocak 2016- Ocak 2022 tarihleri arasında mesane kanseri ön tanısı ile TUR yapılan ve patoloji sonucu mesane karsinomu çıkan; hastane sistemi taranarak verileri elde edilen 252 hasta retrospektif olarak değerlendirildi. Bulgular: Yaş ortalaması erkeklerde 584.3 yıl iken kadınlarda 652.4 yıl olarak saptandı. Ortalama takip süresi 315.2 ay idi. Tümör tipine bakıldığında ise 78i papiller yapıda iken 15 solid ve 7si mikst tipte idi. Patolojik verilere göre hastaların 92sinde üretelyal karsinom 4ünde skuamoz karsinom, 3ünde adenokarsinom ve 1inde nöroendokrin tümör olduğu saptandı. 252 hastanın 162sinde intrakaviter tedavi uygulandığı bunların ise 145i BCG ve 17sinde Epirubisin kullanıldığı görüldü. Nüks olmayan hastaların 80ninin intrakaviter tedavi aldığı, nüks olanların ise 40ının intrakaviter tedavi aldığı görüldü Sonuç: Hastanemizde mesane tümörü tanısı ve tedavisinde altın standart olarak TUR kullanılmakta olup patolojik değerlendirme sonrası klavuzlara uygun olarak intrakaviter tedavi ve kontrol sistoskopileri yapılmaktadır.

Makale detayları

Bladder Tumor Diagnosis, Treatment and Follow-up Results in Our Hospital

Yazarlar:

Hayriye Canik Yaşar | Fatma Zeynep Özen | Adem Yaşar

Yayıncı:

Tokat Gaziosmanpasa University

Ana Başlıklar:

Klinik Tıp Bilimleri

Dergi:

Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi Vol.16 Issue 1, pp.1-6

Belge Tipi:

Makale

Yayın Tarihi:

2/2024

Belge Dili:

Türkçe

Document ID (Org No.):

2001320449

pISSN:

1309-3320

Bladder tumor

İntracavitary treatment

Transurethral resectionİntrakaviter tedavi

Mesane tümörü

Transüretral rezeksiyon

Sayı

Makale detayları

Bladder Tumor Diagnosis, Treatment and Follow-up Results in Our Hospital

Yazarlar: Hayriye Canik Yaşar | Fatma Zeynep Özen | Adem Yaşar

Yayıncı: Tokat Gaziosmanpasa University

Ana Başlıklar: Klinik Tıp Bilimleri

Dergi: Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi Vol.16 Issue 1, pp.1-6

Belge Tipi: Makale

Yayın Tarihi: 2/2024

Belge Dili: Türkçe

Document ID (Org No.): 2001320449

pISSN: 1309-3320

Bladder tumor

İntracavitary treatment

Transurethral resectionİntrakaviter tedavi

Mesane tümörü

Transüretral rezeksiyon

Sayı

Yazarlar:

Hayriye Canik Yaşar | Fatma Zeynep Özen | Adem Yaşar

Yayıncı:

Tokat Gaziosmanpasa University

Ana Başlıklar:

Klinik Tıp Bilimleri

Dergi:

Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi Vol.16 Issue 1, pp.1-6

Belge Tipi:

Makale

Yayın Tarihi:

2/2024

Belge Dili:

Türkçe

Document ID (Org No.):

2001320449

pISSN:

1309-3320